A pill a day, or two, for hepatitis B?

Lancet

Volumn 353, Issue 9158, 1999, Pages 1032-1033

  Dusheiko, G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

HEPATITIS B; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033608828     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)00294-3     Document Type: Note

References (17)

1. JL Dienstag RP Perrillo ER Schiff M Bartholomew C Vicary M Rubin A preliminary trial of lamivudine for chronic hepatitis B infection N Engl J Med 333 1995 1657 1661
2. CL Lai RN Chien NW Leung A one-year trial of lamivudine for chronic hepatitis B N Engl J Med 339 1998 61 68
3. NC Tassopoulos R Volpes G Pastore Efficacy of lamivudine in patients with hepatitis B e antigne-negative/hepatitis B virus DNA-posiotive (precore mutant) chronic hepatitis B Hepatology 29 1999 889 896
4. L Grellier D Mutimer M Ahmed Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis Lancet 348 1996 1212 1215
5. TM Chan PC Wu FK Li CL Lai IK Cheng KN Lai Treatment of fibrosing cholestatic hepatitis with lamivudine Gastroenterology 115 1998 177 181
6. JR Nery D Weppler M Rodriguez P Ruiz ER Schiff AG Tzakis Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation Transplantation 65 1998 1615 1621
7. M Kruger H.L Tillman C Trautwein Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study Liver Transplantation and surgery 2 1996 253 262
8. A Foli KM Sogocio B Anderson In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-[2-(phosphonomethoxy)ethyl]adenine(PMEA) Antiviral Res 32 1996 91 98
9. RJC Gilson K Chopra I Murray-Lyon A placebo-controlled phase I/II study of adefovir dipivoxil (BIS-POM PMEA) in patients with chronic hepatitis B infection Hepatology 24 1996 281a (abstr)
10. SF Innaimo M Seifer GS Bisacchi DN Strandring R Zahler RJ Colonno Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus Antimicrob. Agents Chemother 41 1997 1444 1448
11. R Ling D Mutimer N Ahmed Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine Hepatology 24 1996 711 713
12. YO Jung YS Lee WS Yang DJ Han JS Park SK Park Treatment of chronic hepatitis B with lamivudine in renal transplant recipients Transplantation 66 1998 733 737
13. C Boni A Bertoletti A Penna Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B J Clin Invest 102 1998 968 975
14. AE Heald PH Hsyu GJ Yuen P Robinson P Mydlow JA Bartlett Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction Antimicrobial Agents Chemother 40 1996 1514 1519
15. M Melegari PP Scaglioni JR Wands Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective Hepatology 27 1998 628 633
16. BE Korba In vitro evaluation of combination therapies against hepatitis B virus replication Antiviral Res 29 1996 49 51
17. JS Markowitz P Martin AJ Conrad Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin Hepatology 28 1998 585 589